News

Susan Feigin Harris Talks to Bloomberg about Potential Changes in Medicare

News / November 18, 2016

Partner Susan Feigin Harris is quoted in an article published Nov. 17, 2016, by Bloomberg BNA’s Health Law Daily Report. The article, “Republicans to Push Medicare Changes in 2017, Budget Chairman Says,” discusses potential upcoming changes to Medicare under the Trump administration. Harris told Bloomberg that some privatization of Medicare and combination of Parts A and B, among other actions, will be the likely goals of Republican lawmakers.

Read the article (registration required).

Blog

In The Blogs

Previous Next
Health Law Update
Capitol Hill Healthcare Update
November 13, 2017
SENATE COMMITTEES TO REVIEW TRUMP’S HHS PICK The year-end schedules of the Senate HELP and Finance committees just became more clogged, as the two panels will lead the review of President Trump’s nominee to be Health & Human Services (HHS)...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
November 6, 2017
December Most Likely Timetable for CHIP Even After House Approval The House last week voted to renew the Children’s Health Insurance Program (CHIP) through 2022, but disagreements over how to pay for the program are likely to delay...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
October 30, 2017
House Plans CHIP Vote This Week but Final Action Not Likely Until December House Majority Leader Kevin McCarthy (R-Calif.) said lawmakers will vote this week on legislation to renew federal funding for the Children’s Health Insurance...
Read More ->
Health Law Update
Physicians in the Bulls-eye
October 25, 2017
Several recently reported cases highlight the growing risk physicians face if they succumb to competitive pressures, especially offers of remuneration from labs, pharmacies, home health agencies and other providers to whom they refer. In...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
October 23, 2017
White House Eyes Panel on Drug Prices While Senators Call for Transparency President Donald Trump is considering appointing lawmakers to a bipartisan commission that would develop strategies to lower prescription drug prices, while...
Read More ->